Overview

Outpace Bio develops AI-powered protein design to create proteins that program engineered cells for improved cancer therapy. It focuses on solid tumors by designing proteins that guide immune responses, boost potency and persistence, and enhance safety and specificity, enabling cell therapies to better recognize and eliminate cancer in the body. The platform can power any cell type and manufacturing approach, making it a versatile option in biotech. The company aims to cure solid tumors by overcoming tumor immune suppression, increasing cell therapy durability, and improving efficacy and safety across diverse cancer indications.